Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Biomaterials. 2015 Feb 19;51:208–215. doi: 10.1016/j.biomaterials.2015.02.015

Figure 3.

Figure 3

Figure 3

Efficacy of NP vorinostat and NP quisinostat as radiosensitizers in PC3, DU145, HCT116, SW620, and SW837 cell lines in vitro. Cells were treated with saline, vorinostat, quisinostat, NP vorinostat or NP quisinostat. The cells were then irradiated at different doses (2 Gy, 4 Gy, 6 Gy and 8 Gy). Surviving fractions of the cells were calculated at each radiotherapy dose. Error bars correspond to the standard error of the mean (n=3).